Stock SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-06-10 am EDT 		5-day change 1st Jan Change
1,513 INR +0.41% Intraday chart for Sun Pharmaceutical Industries Ltd. +4.13% +20.14%
Jun. 07 Sun Pharmaceutical to Acquire 9.6% Stake in Genome Software Haystack Analytics MT
Jun. 06 Sun Pharmaceutical Industries Limited agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sun Pharmaceutical to Acquire 9.6% Stake in Genome Software Haystack Analytics
MT
Sun Pharmaceutical Industries Limited agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million.
CI
Philogen, Inc. and Sun Pharmaceutical Industries Limited Announces Results of the Phase III PIVOTAL Trial of Nidlegy in Melanoma
CI
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
RE
Sun Pharma to Pursue M&A
CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical
MT
Indian Equities Hit Intraday Record Highs on Thursday, Lifted by Easing Poll Worries, Strong Domestic Buying
MT
Sun Pharmaceutical Clocks Gains in Fiscal Q4 Consolidated Net Profit
MT
Sun Pharmaceutical Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
India's Sun Pharma beats Q4 profit estimates
RE
Sun Pharmaceutical Industries Limited Recommends Final Dividend for the Financial Year 2023-2024
CI
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
RE
Sun Pharmaceutical Industries Limited entered into an agreement to acquire Valstar Investment S.a. for an enterprise value of $31 million.
CI
Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade
MT
Sun Pharmaceutical's Dadra, India Unit Gets 'Official Action Indicated' Status from US FDA
MT
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes
RE
Bausch wins US appeal to block Alvogen generic of diarrhea drug
RE
Sun Pharmaceutical's Acne Drug Gets Approval in Australia
MT
Sun Pharmaceutical Industries Limited Announces Approval of Winlevi in Australia
CI
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUNPHARMA Stock
  4. News Sun Pharmaceutical Industries Ltd.
  5. Highlights